July 20, 2022
Video
Dr Matthew Lunning closes his discussion on DLBCL by highlighting unmet needs in the treatment landscape.
July 20, 2022
Video
Matthew Lunning, DO, FACP, shares data from the RE-MIND2 trial and explains how it compares to the L-MIND trial.
July 20, 2022
Video
A review of the methods and data from a clinical trial investigating a combination therapy for relapsed/refractory DLBCL.
July 20, 2022
Video
Dr Matthew Lunning describes the available third- and subsequent-line treatments for patients with relapsed/refractory DLBCL (R/R DLBCL) who aren’t eligible for transplant.
July 20, 2022
Video
An expert explains the options for patients with DLBCL who develop chemorefractory disease in second-line treatment.
July 20, 2022
Video
Matthew Lunning, DO, FACP, presents the case of a 64-year-old man with diffuse large B-cell lymphoma (DLBCL) and shares his initial impressions.